MYOCARDIAL REPERFUSION INJURY

MYOCARDIAL REPERFUSION INJURY was reported 38 times

MYOCARDIAL REPERFUSION INJURY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Lymphocyte Growth Factor [EPC] 1 0.0008
1 Typical Antipsychotic [EPC] 18 0.0007
2 Somatostatin Analog [EPC] 1 0.0001
3 Serotonin-3 Receptor Antagonist [EPC] 17 0.0001
4 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
5 Osmotic Laxative [EPC] 12 0.0000
6 Atypical Antipsychotic [EPC] 18 0.0000
7 Glycopeptide Antibacterial [EPC] 2 0.0000
8 Benzodiazepine [EPC] 19 0.0000
9 General Anesthetic [EPC] 1 0.0000
10 Complement Inhibitor [EPC] 1 0.0000
11 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
12 alpha-Adrenergic Blocker [EPC] 2 0.0000
13 Cardiac Glycoside [EPC] 1 0.0000
14 Catecholamine [EPC] 1 0.0000
15 Nitrate Vasodilator [EPC] 1 0.0000
16 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
17 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
18 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
19 Parathyroid Hormone Analog [EPC] 1 0.0000
20 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
21 Sulfonylurea [EPC] 1 0.0000
22 Fluoroquinolone Antibacterial [EPC] 1 0.0000
23 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
24 beta-Adrenergic Blocker [EPC] 2 0.0000
25 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
26 Expectorant [EPC] 1 0.0000
27 Mood Stabilizer [EPC] 1 0.0000
28 Anti-epileptic Agent [EPC] 1 0.0000
29 Loop Diuretic [EPC] 2 0.0000
30 Alkylating Drug [EPC] 1 0.0000
31 Platinum-based Drug [EPC] 1 0.0000
32 Factor Xa Inhibitor [EPC] 1 0.0000
33 Platelet Aggregation Inhibitor [EPC] 2 0.0000
34 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
35 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
36 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
37 Proton Pump Inhibitor [EPC] 1 0.0000